Investisseurs

Juin 2023

INTERIM MD&A – QUARTERLY HIGHLIGHTS FOR THE NINE-MONTH PERIOD ENDED June 30, 2022

Condensed Interim Financial Statements For the Years Ended June 30, 2023

Mars 2023

INTERIM MD&A – QUARTERLY HIGHLIGHTS FOR THE NINE-MONTH PERIOD ENDED MARCH 31, 2022

Condensed Interim Financial Statements For the Years Ended March 31, 2023

December 2022

INTERIM MD&A – QUARTERLY HIGHLIGHTS FOR THE NINE-MONTH PERIOD ENDED DECEMBER 31, 2022

Condensed Interim Financial Statements For the Three- and Nine-Month Periods Ended December 31, 2022 and 2021

September 2022

INTERIM MD&A – QUARTERLY HIGHLIGHTS FOR THE SIX-MONTH PERIOD ENDED SEPTEMBER 30, 2022

Condensed Interim Financial Statements For the Three- and Six-Month Periods Ended September 30, 2022 and 2021

Juin 2022

INTERIM MD&A – QUARTERLY HIGHLIGHTS FOR THE THREE-MONTH PERIOD ENDED JUNE 30, 2022

Condensed Interim Financial Statements For the Three Month Periods Ended June 30, 2022 and 2021

Mars 2022

INTERIM MD&A – QUARTERLY HIGHLIGHTS FOR THE YEAR ENDED MARCH 31, 2022

December 2021

Condensed Interim Financial Statements For the Three and Nine Months Ended December 31, 2021

September 2021

INTERIM MD&A – QUARTERLY HIGHLIGHTS FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2021

Condensed Interim Financial Statements For the Three and Six Months Ended September 30, 2021

Juin 2021

INTERIM MD&A – QUARTERLY HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2021

Condensed Interim Financial Statements For the Three Months Ended June 30, 2021

Mars 2021

Condensed Interim Financial Statements For the Years Ended March 31, 2021